The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines

被引:0
|
作者
J P de Souza Filho
Z M S Correa
J C Marshall
E Anteka
A B Coutinho
M C Martins
机构
[1] The Henry C Witelson Ocular Pathology Laboratory,Ophthalmology Department
[2] McGill University,Department of Ophthalmology
[3] Federal University of São Paulo,undefined
[4] Retina and Oncology Services,undefined
[5] Santa Casa of Porto Alegre,undefined
来源
Eye | 2006年 / 20卷
关键词
COX-2; retinoblastoma; nepafenac; cell lines; immunocytochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:598 / 601
页数:3
相关论文
共 50 条
  • [21] Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor
    Wuest, Frank
    Kniess, Torsten
    Bergmann, Ralf
    Pietzsch, Jens
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (16) : 7662 - 7670
  • [22] Renal cyclooxygenase-2 (Cox-2) -: Physiological, pathophysiological, and clinical implications
    Krämer, BK
    Kammerl, MC
    Kömhoff, M
    KIDNEY & BLOOD PRESSURE RESEARCH, 2004, 27 (01) : 43 - 62
  • [23] 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
    Talley, JJ
    Bertenshaw, SR
    Brown, DL
    Carter, JS
    Graneto, MJ
    Koboldt, CM
    Masferrer, JL
    Norman, BH
    Rogier, DJ
    Zweifel, BS
    Seibert, K
    MEDICINAL RESEARCH REVIEWS, 1999, 19 (03) : 199 - 208
  • [24] Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma
    Upadhyay, Rohit
    Jain, Meenu
    Kumar, Shaleen
    Ghoshal, Uday Chand
    Mittal, Balraj
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 663 (1-2) : 52 - 59
  • [25] Synthesis of 18F-labeled cyclooxygenase-2 (COX-2) inhibitor as a potential PET imaging agent
    Tian, Haibin
    Lee, Zhenghong
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (07) : 583 - 593
  • [26] Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade
    Lin, CD
    Kenyon, L
    Hyslop, T
    Hammond, E
    Andrews, DW
    Curran, WJ
    Dicker, AP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S98 - S102
  • [27] Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats
    Turull, A
    Queralt, J
    IMMUNOPHARMACOLOGY, 2000, 46 (01): : 71 - 77
  • [28] Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer
    Buecher, B
    Heymann, MF
    Blottière, HM
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2001, 25 (11): : 967 - 978
  • [29] Metal Enhanced Electrochemical Cyclooxygenase-2 (COX-2) Sensor for Biological Applications
    Noah, Naumih M.
    Marcells, Omole
    Almalleti, Anas
    Lim, Jae
    Sadik, Omowunmi A.
    ELECTROANALYSIS, 2011, 23 (10) : 2392 - 2399
  • [30] Expression of Cyclooxygenase-2 (COX-2) in Colorectal Adenocarcinoma: an Immunohistochemical and Histopathological Study
    Mahmoud, Abla Sayed
    Umair, Ayesha
    Azzeghaiby, Saleh Nasser
    Alqahtani, Fahad Hussain
    Hanouneh, Salah
    Tarakji, Bassel
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6787 - 6790